Chronic Kidney Disease Market

Jul 31, 2020

10 likes | 71 Views

In 2017, the total prevalent population of Chronic Kidney Disease (CKD) was found to be 122,704,658 in the seven major markets. The prevalent population of Chronic Kidney Disease in the United States was 35,288,932 while Japan had 21,183,442 prevalent cases of CKD in 2017. The market size of Chronic Kidney Disease (CKD) in the 7MM is estimated to be USD 16,897.5 Million by 2030. Advances and future research, increasing prevalence of CKD, opportunities associated with CKD, and early detection & precision medicine are some of key factors expected to drive the CKD market forward in the coming years. Some of the key players in the Chronic Kidney Disease (CKD) market includes GlaxoSmithKline, Akebia Therapeutics, Tricida Pharma, AstraZeneca, FibroGen, Astellas Pharma, Corvidia Therapeutics, Boehringer Ingelheim, Reata Pharmaceuticals and many others. For more details visit: https://www.delveinsight.com/report-store/chronic-kidney-disease-chronic-renal-failure-market

DelveInsight

Download Presentation

Chronic Kidney Disease Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D